You'll see more women taking Evista (raloxifene) to TREAT osteoporosis

November 1999

You'll see more women taking Evista (raloxifene) to TREAT osteoporosis. It was initially approved for prevention...but new research shows it's also effective for treatment.

In fact, Evista is now approved in the U.S. for treatment.

Evista decreases vertebral fractures up to 50%...in postmenopausal women who take it for 3 years.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 120+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote